Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Urinalysis Market Worth USD 6.8 Billion by 2029: Growth Drivers, Key Players, and Trends | MarketsandMarkets™


News provided by

MarketsandMarkets

26 Jun, 2024, 14:30 GMT

Share this article

Share toX

Share this article

Share toX

CHICAGO, June 26, 2024 /PRNewswire/ -- The urinalysis market, valued at USD 4.3 billion in 2024 and projected to grow to USD 6.8 billion by 2029 with a CAGR of 9.6%, is driven by several key factors. These include the rising prevalence of chronic and lifestyle diseases, technological advancements in point-of-care (PoC) testing products, and growing patient awareness. Moreover, the market faces challenges such as high capital investments and a shortage of skilled laboratory technicians. Opportunities lie in advancements in urine analyzers, particularly automated systems, and overcoming regulatory hurdles in the changing landscape of in vitro diagnostics (IVD). Major players like Siemens Healthineers, F. Hoffmann-La Roche Ltd., Cardinal Health, Abbott, and Danaher dominate the market with their extensive product portfolios and global presence.

This image opens in the lightbox
MarketsandMarkets Logo


Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294

Browse in-depth TOC on "Urinalysis Market"

483 - Tables
49 - Figures
390 - Pages

Product Segmentation in the Urinalysis Market: Consumables and Instruments

The urinalysis market is segmented into consumables and instruments. Consumables, including pregnancy & fertility kits, dipsticks, reagents, and disposables, dominated the market in 2023. These products are essential for routine testing in hospitals, clinics, and labs, especially for chronic disease monitoring.

Test Types Driving Market Growth: Biochemical, Sediment, and Pregnancy Tests

The urinalysis market is categorized by test types such as biochemical, sediment, and pregnancy & fertility tests. In 2023, pregnancy & fertility tests held the largest market share due to increasing awareness and adoption of home testing options, particularly in developing regions.

Application Insights: Disease Screening Leads Market Demand

Disease screening, including for conditions like UTIs and kidney ailments, accounted for the predominant share of the urinalysis market in 2023. The necessity for regular monitoring of chronic conditions fuels the demand for urinalysis, supporting this segment's growth.

Regional Analysis and Growth Projections: Asia Pacific Shows Highest Potential

The urinalysis market is segmented across North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. Asia Pacific is anticipated to exhibit the highest CAGR, driven by governmental initiatives to enhance healthcare accessibility and fund research in disease diagnostics.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=153479294

Market Leaders Driving Innovation and Expansion

Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), and Cardinal Health (US) emerge as key players in the urinalysis market. In 2023, Siemens Healthineers AG led the market with its extensive product portfolio and strategic investments in research and development. The company's partnerships and expansions reinforce its market dominance, enhancing technological integration across its offerings.

Roche's Dominance in Biochemical Urinalysis

F. Hoffmann-La Roche Ltd. (Switzerland) maintains a significant market share in biochemical urinalysis through its diverse portfolio of urine analyzers and test strips. The company's focus on innovation and substantial investments in R&D underscores its leadership position, bolstered by a robust global distribution network facilitating widespread product accessibility.

Cardinal Health's Strategic Initiatives for Market Expansion

Cardinal Health (US) secured a prominent position in the urinalysis market by optimizing its global supply chain and expanding self-manufacturing capabilities. Notably, the establishment of new distribution centers in Central Ohio in April 2023 exemplifies the company's commitment to enhancing operational efficiency and supporting its US Medical Products and Distribution segments.

Sysmex Corporation Launches Advanced Urine Analyzer

In September 2022, Sysmex Corporation introduced the UF-1500 Fully Automated Urine Particle Analyzer, enhancing diagnostic capabilities in urine sediment testing. This innovation underscores Sysmex's commitment to advancing automated diagnostic solutions for accurate and efficient urine analysis.

Quidel Corporation Expands Diagnostic Portfolio through Acquisition

In May 2022, Quidel Corporation (US) expanded its diagnostic portfolio with the acquisition of Ortho Clinical Diagnostics (US). This strategic move bolsters Quidel's expertise in cellular-based virology assays and molecular diagnostic systems, reinforcing its leadership in the global diagnostics market.

Siemens Healthineers and Unilabs Forge Strategic Partnership

In February 2023, Siemens Healthineers partnered with Unilabs in a multi-year agreement to modernize Unilabs' healthcare infrastructure. This collaboration aims to enhance operational efficiency and customer service across Unilabs' extensive testing network, leveraging Siemens Healthineers' innovative diagnostic solutions.

Cardinal Health Expands Distribution Network for Enhanced Market Reach

Cardinal Health (US) announced in April 2023 the opening of two new distribution centers in Central Ohio. These facilities support Cardinal Health's Medical segment and At-home Solutions businesses, optimizing its global supply chain to meet growing demand and strengthen market leadership.

Siemens Healthineers Innovates with New Erlangen Innovation Center

In July 2023, Siemens Healthineers inaugurated the Erlangen Innovation Center in Germany, focusing on open innovation initiatives. The center fosters collaborations with clinical, academic partners, and startups to drive advancements in healthcare technologies and solutions.

For more information, inquire now! Inquire Now

Related Reports:

Point of Care Diagnostics Market

Clinical Chemistry Analyzers Market

Life Science Instrumentation Market

In Vitro Diagnostics Market

Stoma Care Market

Get access to the latest updates on Urinalysis Companies and Urinalysis Market Size

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg 

Modal title

Also from this source

MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the True Random Number Generator (TRNG) Quadrant Report 2025

MarketsandMarkets' 360Quadrants Recognizes Top Startups and SMEs in the True Random Number Generator (TRNG) Quadrant Report 2025

360Quadrants has released its latest True Random Number Generator (TRNG) Startups/SMEs Companies Assessment, 2025, recognizing key players, including ...

Biosimilars Market worth US$72.29 billion by 2035 with 7.5% CAGR | MarketsandMarkets™

Biosimilars Market worth US$72.29 billion by 2035 with 7.5% CAGR | MarketsandMarkets™

The global Biosimilars Market, valued at US$32.75 billion in 2024 stood at US$35.04 billion in 2025 and is projected to advance at a resilient CAGR...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Medical Equipment

Medical Equipment

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.